Patients with a reported adverse reaction to a Gadolinium-based contrast agent.

Figshare2020-04-03 更新70

Safety outcomes in the patients who received an injection of the investigational product.

临床试验安全性评估

药物不良反应监测

Safety outcomes in the patients who received an injection of the investigational product.

Figshare2019-12-10 更新50

Overall summary of adverse events (treated set).

药物不良反应监测

临床试验安全性分析

aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino

NIAID Data Ecosystem20

Patients with a reported adverse reaction to a Gadolinium-based contrast agent.

资源简介：

相关数据集